Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Peritoneal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05527184
What this trial is testing

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Who this might be right for
Endometrial CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+2 more
AbbVie 256
Early research (Phase 1)Looking for participantsNCT03968406
What this trial is testing

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Who this might be right for
Malignant Female Reproductive System NeoplasmRecurrent Cervical CarcinomaRecurrent Endometrial Carcinoma+22 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07044349
What this trial is testing

Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 72
Not applicableStudy completedNCT02578888
What this trial is testing

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Who this might be right for
Cervical CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma+7 more
Albert Einstein College of Medicine 95
Not applicableStudy completedNCT02179489
What this trial is testing

Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis

Who this might be right for
Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4Peritoneal Carcinomatosis
Zhejiang University 271
Testing effectiveness (Phase 2)Study completedNCT01001910
What this trial is testing

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Albert Einstein College of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00003120
What this trial is testing

S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 308
Testing effectiveness (Phase 2)WithdrawnNCT00369954
What this trial is testing

Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00083122
What this trial is testing

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IIIA Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)UnknownNCT01654146
What this trial is testing

ICON8: Weekly Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council 1,485
Testing effectiveness (Phase 2)Study completedNCT00030446
What this trial is testing

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Study completedNCT00093496
What this trial is testing

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT05065021
What this trial is testing

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+2 more
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Study completedNCT01709487
What this trial is testing

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Jules Bordet Institute 19
Testing effectiveness (Phase 2)Ended earlyNCT01972516
What this trial is testing

Tivozanib As Maintenance Therapy In GYN

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 4
Large-scale testing (Phase 3)UnknownNCT03693248
What this trial is testing

Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more
Seoul National University Hospital 298
Testing effectiveness (Phase 2)Study completedNCT00030706
What this trial is testing

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Montefiore Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT07708753
What this trial is testing

SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-resistant Primary Peritoneal CancerPlatinum-resistant Fallopian Tube Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 460
Testing effectiveness (Phase 2)Study completedNCT00388037
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+12 more
National Cancer Institute (NCI) 31
Next Page